B7-H3/CD3 BiTE-IL15 fusion Protein

N/A

Report date: 2026/04/21 20:00:18

Base Information

Drug NameB7-H3/CD3 BiTE-IL15 fusion Protein
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-CD276CD3 T-cell engagersInterleukin-15 stimulants +[4] 
TargetsCD276 antigenT cell surface glycoprotein CD3Interleukin-15 +[4] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSunHo (China) BioPharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSunHo (China) BioPharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A